—

Boston Scientific Corp (BSX) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for BSX, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.29 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How BSX has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.29 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Boston Scientific Corp moved 0.29% on average · correlation 0.07 · higher than 28% of US names
  • Beta, last 3 months 0.64 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.62% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +0.13% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BSX on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Boston Scientific Corp

BSX in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Boston Scientific designs and sells medical devices used in specialist interventional procedures, organised into two segments. MedSurg covers gastrointestinal, urological and neuromodulation tools such as stents, scopes and nerve-ablation systems, while Cardiovascular covers heart devices including the WATCHMAN closure implant, defibrillators, pacemakers and rhythm-monitoring systems. It sells to hospitals and physicians worldwide and is headquartered in Marlborough, Massachusetts.
Where it sits in the stack
Boston Scientific carries no seat in Rubin or Halo, our AI build-out indices; it sits instead in our Healthcare sleeve, under medical devices, well outside the compute stack the diary otherwise tracks.
Who it is priced against
Closelooknet's peer group is not set for this name; the comparison the market draws is with Medtronic, another broad-line device maker spanning cardiac and other specialties.
Why Closelooknet tracks it
It is an S&P 500 constituent but holds no Rubin or Halo seat and carries no Closelooknet score yet; the diary has not quoted it in the dailies.
What the diary watches
Whether approvals, recalls or launches in its cardiac and neuromodulation lines move the reading, since procedure volumes drive this name far more than the wider AI build-out.

Boston Scientific Corp (BSX) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 2 analyst actions on the wire · latest: price target by Wells Fargo, 2026-09-23

The Street on this name

Analyst actions and the latest print for BSX from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Wells Fargo — target 48 from 50 Target cut to $48 from $50 (+7.6% to spot) 2026-09-23
  • Price target Oppenheimer — target 65 from 85 Target cut to $65 from $85 (+50% to spot) 2026-09-21

2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Boston Scientific Corp (BSX)?

Boston Scientific Corp trades as BSX on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is BSX in a Closelooknet index?

Not currently — Boston Scientific Corp is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does BSX trade against its moving averages?

Downtrend stack: Trades -6.3% vs the 50-day and -30.2% vs the 200-day average, 58.4% below the 52-week high and +4.1% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Boston Scientific Corp trade when bond yields rise?

Over the past year Boston Scientific Corp had a beta of 0.29 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 28% of US names. On the 10 sessions in which long bonds fell most it moved −0.62% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Boston Scientific Corp do?

Boston Scientific designs and sells medical devices used in specialist interventional procedures, organised into two segments. MedSurg covers gastrointestinal, urological and neuromodulation tools such as stents, scopes and nerve-ablation systems, while Cardiovascular covers heart devices including the WATCHMAN closure implant, defibrillators, pacemakers and rhythm-monitoring systems. It sells to hospitals and physicians worldwide and is headquartered in Marlborough, Massachusetts. Closelooknet's peer group is not set for this name; the comparison the market draws is with Medtronic, another broad-line device maker spanning cardiac and other specialties.

Where does Boston Scientific Corp sit in the AI build-out?

Boston Scientific carries no seat in Rubin or Halo, our AI build-out indices; it sits instead in our Healthcare sleeve, under medical devices, well outside the compute stack the diary otherwise tracks. It is an S&P 500 constituent but holds no Rubin or Halo seat and carries no Closelooknet score yet; the diary has not quoted it in the dailies.

What has Wall Street done on Boston Scientific Corp recently?

The most recent analyst action on Boston Scientific Corp on the Closelooknet wire is a price target by Wells Fargo on 2026-09-23 (target 48 from 50). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for BSX, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.